Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Cetuximab × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 8 Head & Neck 5 Genitourinary 3 Breast 3 Thoracic 2 Gastrointestinal 2 Myeloid 1 Lymphoid 1 Gynecologic 1 Dermatologic 1 CNS 1

Conditions

Melanoma 7 Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 3 Skin Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Renal Cell 3 Stomach Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Kidney Neoplasms 2 Head and Neck Neoplasms 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Lung Neoplasms 1 Glioma 1 Endometrial Neoplasms 1 Carcinoma, Hepatocellular 1 Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 16 pembrolizumab 14 Radiosurgery 7 Nivolumab 5 Celecoxib 5 poly ICLC 4 Radiation 4 Injections 4 Radiotherapy 3 Melphalan 3 Ipilimumab 3 Filgrastim 3 Etoposide 3 Docetaxel 3 Cryosurgery 3 Blood Specimen Collection 3 Biopsy 3 130-nm albumin-bound paclitaxel 3 trastuzumab deruxtecan 2 tislelizumab 2 talimogene laherparepvec 2 spartalizumab 2 fludarabine phosphate 2 fludarabine 2 durvalumab 2 cemiplimab 2 atezolizumab 2 aldesleukin 2 Transurethral Resection of Prostate 2 Therapeutics 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03009058 2024-11-25

MODULATE

Immodulon Therapeutics Ltd

Phase 1/2 Terminated

2 enrolled 7 charts

DermatologicSarcoma

Melanoma, Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡